Deregulated intracellular signaling by mutated c-CBL in myeloid neoplasms.
about
The paradox of conformational constraint in the design of Cbl(TKB)-binding peptidesChallenging the axiom: does the occurrence of oncogenic mutations truly limit cancer development with age?High-throughput fluorescence polarization assay to identify inhibitors of Cbl(TKB)-protein tyrosine kinase interactions.Peptide truncation leads to a twist and an unusual increase in affinity for casitas B-lineage lymphoma tyrosine kinase binding domain.Indispensable roles of mammalian Cbl family proteins as negative regulators of protein tyrosine kinase signaling: Insights from in vivo modelsInduction of c-Cbl contributes to anti-cancer effects of HDAC inhibitor in lung cancer.H19 non coding RNA-derived miR-675 enhances tumorigenesis and metastasis of breast cancer cells by downregulating c-Cbl and Cbl-b.UBASH3B/Sts-1-CBL axis regulates myeloid proliferation in human preleukemia induced by AML1-ETO.Casitas B-cell lymphoma mutation in childhood T-cell acute lymphoblastic leukemiaCBL mutations in myeloproliferative neoplasms are also found in the gene's proline-rich domain and in patients with the V617FJAK2.c-CBL regulates melanoma proliferation, migration, invasion and the FAK-SRC-GRB2 nexus.Hrs and STAM function synergistically to bind ubiquitin-modified cargoes in vitro.CBL RING finger deletions are common in core-binding factor acute myeloid leukemias.A point mutation of zebrafish c-cbl gene in the ring finger domain produces a phenotype mimicking human myeloproliferative disease.CBL mutation-related patterns of phosphorylation and sensitivity to tyrosine kinase inhibitors.Casitas B lymphoma mutations in childhood acute lymphoblastic leukemia.Juvenile myelomonocytic leukemia due to a germline CBL Y371C mutation: 35-year follow-up of a large family.
P2860
Q27677282-12171AE9-4B3F-4243-B5DB-554354DE557EQ28383732-EFFA75B6-BD8E-46F8-8E8A-4C18CF3A17EFQ33762830-E7CF7762-2202-458E-9498-4CE92EFD92B5Q34186412-C3D5AB3B-2384-4742-9B40-9ED001BE340AQ35015130-B323E5D5-7E8A-4AA6-92B0-FDAB6E3FF9ADQ35828611-0EC5E6F9-8230-4316-BAD9-07CDCA4199C7Q36557258-EFBEDC0B-42E1-4C10-B209-18F09735C9E8Q36642902-BD15B8A9-51E2-4DED-A133-93352A756055Q36958309-960EF026-657B-48C7-9A58-D2430C0A4A8FQ39399799-1736E4B6-5705-448F-9EC2-F03E32404ED1Q42059163-B00CB669-3DED-4804-87BA-847F0EFB1A5EQ43095092-198C4565-FE0B-45AF-8B77-8F269A0141C7Q44076785-6FCD7113-CA95-41EB-8F03-DDBD9F3F0619Q53456278-BC3935A1-2820-4A5F-BC70-3D46C30FE056Q54329349-A6B405A4-0288-4D2A-B45F-BF9B5929D10DQ54550986-EB32BD08-D5AB-43FE-9DB8-1A0FF05F1182Q55059089-8C4D773A-BF02-4434-B7CD-34A73DFF52B2
P2860
Deregulated intracellular signaling by mutated c-CBL in myeloid neoplasms.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 June 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Deregulated intracellular signaling by mutated c-CBL in myeloid neoplasms.
@en
Deregulated intracellular signaling by mutated c-CBL in myeloid neoplasms.
@nl
type
label
Deregulated intracellular signaling by mutated c-CBL in myeloid neoplasms.
@en
Deregulated intracellular signaling by mutated c-CBL in myeloid neoplasms.
@nl
prefLabel
Deregulated intracellular signaling by mutated c-CBL in myeloid neoplasms.
@en
Deregulated intracellular signaling by mutated c-CBL in myeloid neoplasms.
@nl
P2093
P1476
Deregulated intracellular signaling by mutated c-CBL in myeloid neoplasms
@en
P2093
H Phillip Koeffler
Hiromitsu Nakauchi
Lee-Yung Shih
Masashi Sanada
Seishi Ogawa
Takahiro Suzuki
P304
P356
10.1158/1078-0432.CCR-09-2341
P407
P50
P577
2010-06-14T00:00:00Z